Medline Inc. financial data

Symbol
MDLN on Nasdaq
Location
Northfield, IL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 25 Feb 2026

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $13,000,000,000 USD
Weighted Average Number of Shares Outstanding, Basic 809,688,877 shares
Weighted Average Number of Shares Outstanding, Diluted 809,688,877 shares

Income Statement

Label TTM Value / Value Unit Change %
Net Income (Loss) Attributable to Parent $7,000,000 USD
Earnings Per Share, Basic -0.01 USD/shares
Earnings Per Share, Diluted -0.01 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,939,000,000 USD 874%
Accounts Receivable, after Allowance for Credit Loss, Current $3,533,000,000 USD 9.8%
Inventory, Net $4,769,000,000 USD 7%
Other Assets, Current $438,000,000 USD 10%
Assets, Current $10,679,000,000 USD 29%
Deferred Income Tax Assets, Net $583,000,000 USD
Property, Plant and Equipment, Net $4,778,000,000 USD 4%
Operating Lease, Right-of-Use Asset $432,000,000 USD 12%
Intangible Assets, Net (Excluding Goodwill) $13,893,000,000 USD -4.6%
Goodwill $8,079,000,000 USD 0.17%
Other Assets, Noncurrent $23,027,000,000 USD -0.36%
Assets $38,484,000,000 USD 7%
Accounts Payable, Current $961,000,000 USD 11%
Accrued Liabilities, Current $1,452,000,000 USD -2.7%
Liabilities, Current $2,490,000,000 USD 2%
Operating Lease, Liability, Noncurrent $386,000,000 USD 17%
Other Liabilities, Noncurrent $682,000,000 USD 14%
Liabilities $19,198,000,000 USD -1.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $27,000,000 USD 145%
Retained Earnings (Accumulated Deficit) $7,000,000 USD
Stockholders' Equity Attributable to Parent $10,737,000,000 USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $19,286,000,000 USD
Liabilities and Equity $38,484,000,000 USD 7%

Popular Metrics

Label TTM Value / Value Unit Change %
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,942,000,000 USD 677%
Deferred Tax Assets, Valuation Allowance $0 USD -100%
Operating Lease, Liability $452,000,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid $591,000,000 USD
Property, Plant and Equipment, Gross $5,939,000,000 USD 8.9%
Operating Lease, Liability, Current $66,000,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $85,000,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $92,000,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -12%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $139,000,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $77,000,000 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000,000 shares
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $66,000,000 USD
Additional Paid in Capital $10,717,000,000 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $747,000,000 USD 2568%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares